Merit Medical ( (MMSI) ) has realeased its Q3 earnings. Here is a breakdown of the information Merit Medical presented to its investors.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Merit Medical Systems, Inc., a global leader in healthcare technology, specializes in the development, manufacturing, and distribution of medical devices for various interventional and diagnostic procedures, particularly in cardiology and radiology. With a presence worldwide, the company is known for its commitment to innovation and quality in the healthcare sector.
In its third-quarter 2024 earnings report, Merit Medical reported a revenue of $339.8 million, reflecting a 7.8% increase year-over-year. The company also announced an enhanced full-year guidance for 2024, underlining its strategy to capitalize on its recent acquisitions and continued growth initiatives. This positive outlook comes as the company successfully integrates assets from EndoGastric Solutions and prepares for the acquisition of Cook Medical’s lead management portfolio.
Key financial highlights include a GAAP operating margin of 11.0% and a non-GAAP operating margin of 19.2%, representing an improvement from the previous year. The company’s non-GAAP earnings per share rose by 21.1% to $0.86, and it generated a significant free cash flow of $120 million over the first nine months of 2024, marking a 116% increase year-over-year. Additionally, the endoscopy devices segment saw substantial growth with an 85.8% increase in revenue.
Merit Medical’s strategic acquisitions are noteworthy, with the recent purchase of assets from EndoGastric Solutions, including a device for treating gastroesophageal reflux disease, and the anticipated acquisition of Cook Medical’s lead management portfolio. These moves align with the company’s ongoing efforts to expand its product offerings and enhance its market position.
Looking ahead, Merit Medical remains optimistic about its financial performance for the remainder of 2024. The company has updated its full-year guidance, forecasting continued revenue growth and profitability improvements. This outlook is supported by the anticipated contributions from recent acquisitions and a focus on stable growth, increased profitability, and strong cash flow generation.
